Eyegate Pharmaceuticals, Inc. (EYEG) financial statements (2021 and earlier)

Company profile

Business Address 271 WAVERLEY OAKS ROAD
WALTHAM, MA 02452
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments148848
Cash and cash equivalents148848
Receivables000001
Other undisclosed current assets110100
Total current assets:248849
Noncurrent Assets
Property, plant and equipment00000 
Intangible assets, net (including goodwill)1366   
Goodwill322   
Intangible assets, net (excluding goodwill)1044   
Restricted cash and investments000000
Other noncurrent assets00000 
Other undisclosed noncurrent assets   550
Total noncurrent assets:1366660
TOTAL ASSETS:151014141010
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities211332
Accounts payable000110
Accrued liabilities111221
Deferred revenue and credits1242
Other undisclosed current liabilities003   
Total current liabilities:2141573
Noncurrent Liabilities
Long-term debt and lease obligation0  00 
Long-term debt, excluding current maturities0     
Capital lease obligations 00 
Operating lease, liability0 
Liabilities, other than long-term debt62113 
Deferred tax liabilities, net0 2 
Deferred income tax liabilities10
Business combination, contingent consideration, liability52111 
Other undisclosed noncurrent liabilities   0  
Total noncurrent liabilities:62113 
Total liabilities:83516103
Stockholders' equity
Stockholders' equity attributable to parent779(2)(0)6
Preferred stock0000  
Common stock000000
Additional paid in capital115107102907871
Accumulated other comprehensive income (loss)(0)00000
Accumulated deficit(108)(100)(93)(92)(79)(65)
Receivable from shareholders or affiliates for issuance of capital stock    (0)(0)
Total stockholders' equity:779(2)(0)6
TOTAL LIABILITIES AND EQUITY:151014141010

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues03201 
Revenue, net01 
Cost of revenue
(Cost of Goods and Services Sold)
     (0)
Gross profit:03201(0)
Operating expenses(8)(10)(12)(15)(14)(7)
Operating loss:(8)(7)(11)(15)(13)(7)
Nonoperating income (expense)000(0)0(2)
Investment income, nonoperating000000
Interest and debt expense(0)(0)(0)(0)(0)(1)
Other undisclosed income from continuing operations before equity method investments, income taxes161421001
Income (loss) from continuing operations before equity method investments, income taxes:8711(15)(13)(8)
Other undisclosed loss from continuing operations before income taxes(16)(14)(21)   
Loss from continuing operations before income taxes:(8)(7)(11)(15)(13)(8)
Income tax expense (benefit)(0)(0)(0)1  
Loss before gain (loss) on sale of properties:(8)(7)(11)(13)(13)(8)
Other undisclosed net income     0
Net loss:(8)(7)(11)(13)(13)(8)
Net loss attributable to noncontrolling interest     (0)
Net loss attributable to parent:(8)(7)(11)(13)(13)(8)
Preferred stock dividends and other adjustments     (8)
Net loss available to common stockholders, diluted:(8)(7)(11)(13)(13)(17)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss:(8)(7)(11)(13)(13)(8)
Other undisclosed comprehensive income (loss)(0)0000 
Comprehensive loss:(8)(7)(11)(13)(13)(8)
Comprehensive income, net of tax, attributable to noncontrolling interest     0
Other undisclosed comprehensive income, net of tax, attributable to parent     0
Comprehensive loss, net of tax, attributable to parent:(8)(7)(11)(13)(13)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: